N

Nektar Therapeutics
D

NKTR

8.54000
USD
-0.21
(-2.40%)
مغلق
حجم التداول
18,758
الربح لكل سهم
-13
العائد الربحي
-
P/E
-1
حجم السوق
105,954,969
أصول ذات صلة
A
ALKS
-0.950
(-3.09%)
29.830 USD
AMGN
AMGN
-2.10
(-0.70%)
295.22 USD
BIIB
BIIB
-1.660
(-1.25%)
130.660 USD
BMRN
BMRN
-1.000
(-1.75%)
56.220 USD
GILD
GILD
-2.080
(-1.86%)
110.010 USD
INCY
INCY
-1.490
(-2.15%)
67.750 USD
LLY
LLY
7.54
(0.93%)
819.54 USD
MRK
MRK
-0.050
(-0.06%)
81.740 USD
PFE
PFE
-0.315
(-1.27%)
24.535 USD
REGN
REGN
7.50
(1.44%)
529.39 USD
المزيد
الأخبار المقالات

العنوان: Nektar Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.